is rybelsus a glp-1 drug Novo's gains FDA expansion to reduce risk of MACE Rybelsus: Package Insert / Prescribing
Description
This acquisition is aimed at enhancing its portfolio with the addition of Metsera's Next-Generation Obesity Portfolio.

Learn why GLP-1 drugs cannot rebuild metabolism, and how SCFAs & gut bacteria may support lasting balance

Well, thats exactly what happened with the GLP-1 receptor agonists

#GLP1 #DiabetesCare #ObesityManagement #PharmaIndustry #ClinicalResearch #DrugDevelopment #HealthcareInnovation #Endocrinology #Biotech #RegulatoryAffairs

In addition, perioperative management of patients on GLP-1 RAs requires careful assessment as a result of delayed gastric emptying and the associated potential risk of pulmonary aspiration
